economic burden and challenges of trial of sma
Published 5 years ago • 59 plays • Length 6:30Download video MP4
Download video MP3
Similar videos
-
8:50
zolgensma and the start trial for sma
-
4:44
patient perspective and payer perspective of sma
-
5:13
spinal muscular atrophy (sma) and types of sma
-
18:36
cure sma and biogen's respond clinical trial webinar
-
47:27
2021 virtual sma conference: understanding treatment, trials and care of a pre-symptomatic diagnosis
-
39:56
cure sma and biohaven pharmaceuticals clinical trial update webinar
-
35:59
⭐️ parenting facilitation - help for high conflict co-parents (2022) | jennifer hargrave show e47
-
1:03:13
1 hour of beautiful hymns with lyrics! (rosemary siemens)
-
4:04
what's sma disease and why is it's treatment so expensive? | newsmo
-
24:58
altering the natural history of spinal muscular atrophy
-
28:16
insufficient levels of pms2, ercc1, ku86, and ccoi contribute in the progression of colon cancer
-
8:06
risdiplam and final thoughts
-
4:22
the cost of sma treatment is balanced by positive outcomes
-
32:01
lessons learned from sma – what happens when a clinical trial works!
-
0:52
dr jeff sharman: cost of therapy is a major challenge in cll
-
44:52
april 2022 cure sma and novartis gene therapies clinical trial update webinar
-
4:25
mary schroth, md: the challenge of early sma recognition
-
4:06
spr1nt trial of onasemnogene abeparvovec for sma
-
3:35
diagnostic tests and scales of sma
-
36:08
helping patients with sma understand diagnosis and treatment in a new era of therapy
-
5:25
key differences between spinraza and zolgensma
-
1:29:27
mduk muscles matter 2022: spinal muscular atrophy (adult focus)